KKR aims to accelerate Bushu Pharma’s growth and further position the company as a leading contract development and manufacturing organization
The company additionally applies advanced quality control processes and supply chain management support for the inspection, packaging and distribution of pharmaceutical products
. Bushu Pharma has Good Manufacturing Practice (GMP) certifications globally, and manufactures products for worldwide end-markets, with a particular focus on Japan and Asian countries, such as China.
Following the transaction’s close, KKR plans to work alongside Bushu Pharma’s management team to expand into new and growing segments, such as injectables, invest in further capacity expansion and quality control